LON:APH - Alliance Pharma Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 79.77 +1.77 (+2.27 %) (As of 12/9/2019 10:36 AM ET) Add Compare Today's Range 77.27Now: GBX 79.77▼ 80.4050-Day Range 71MA: GBX 74.43▼ 80.3052-Week Range 59.20Now: GBX 79.77▼ 82.40Volume1.20 million shsAverage Volume488,126 shsMarket Capitalization£419.69 millionP/E Ratio19.46Dividend Yield1.93%BetaN/A ProfileAnalyst RatingsAdvanced ChartDividendInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Alliance Pharma plc operates as a specialty pharmaceutical company in the United Kingdom, rest of Europe, and internationally. The company acquires, markets, and sells pharmaceutical products. It acquires the rights of established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The company also provides prescription only medicines, over the counter medications, cosmetics, and nutritional supplements, as well as medical devices. Read More… Industry, Sector and Symbol Stock Exchange LON Industry Drugs - Generic Sub-IndustryN/A SectorMedical Current SymbolLON:APH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.alliancepharma.co.uk/ Phone+44-1249-466966Debt Debt-to-Equity Ratio36.49 Current Ratio0.64 Quick Ratio0.42Price-To-Earnings Trailing P/E Ratio19.46 Forward P/E Ratio0.18 P/E GrowthN/A Sales & Book Value Annual Sales£129.76 million Price / Sales3.23 Cash FlowGBX 3.25 per share Price / Cash Flow24.56 Book ValueGBX 49.70 per share Price / Book1.60Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees200 Outstanding Shares526,144,000Market Cap£419.69 million Next Earnings DateN/A OptionableOptionable Receive APH News and Ratings via Email Sign-up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter. LSE:APH Rates by TradingView Alliance Pharma (LON:APH) Frequently Asked Questions What is Alliance Pharma's stock symbol? Alliance Pharma trades on the London Stock Exchange (LON) under the ticker symbol "APH." How often does Alliance Pharma pay dividends? What is the dividend yield for Alliance Pharma? Alliance Pharma declared a dividend on Tuesday, September 24th. Investors of record on Thursday, December 19th will be paid a dividend of GBX 0.54 per share on Friday, January 10th. This represents a yield of 0.73%. The ex-dividend date is Thursday, December 19th. The official announcement can be accessed at this link. View Alliance Pharma's Dividend History. What price target have analysts set for APH? 1 Wall Street analysts have issued 1 year target prices for Alliance Pharma's shares. Their forecasts range from GBX 115 to GBX 115. On average, they anticipate Alliance Pharma's share price to reach GBX 115 in the next twelve months. This suggests a possible upside of 44.2% from the stock's current price. View Analyst Price Targets for Alliance Pharma. What is the consensus analysts' recommendation for Alliance Pharma? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alliance Pharma. Has Alliance Pharma been receiving favorable news coverage? News headlines about APH stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Alliance Pharma earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Alliance Pharma. Who are some of Alliance Pharma's key competitors? Some companies that are related to Alliance Pharma include STAAR Surgical (STAA), Epizyme (EPZM), Akcea Therapeutics (AKCA), USANA Health Sciences (USNA), Zymeworks (ZYME), Regenxbio (RGNX), Allscripts Healthcare Solutions (MDRX), BioTelemetry (BEAT), Merit Medical Systems (MMSI), Primary Health Care (PRY), Inogen (INGN), Editas Medicine (EDIT), Avanos Medical (AVNS), Karuna Therapeutics (KRTX) and Alder Biopharmaceuticals (ALDR). What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC), Editas Medicine (EDIT), 1-800-Flowers.Com (FLWS), BlackBerry (BB), Direct Line Insurance Group (DLG), Telford Homes (TEF), XLMedia (XLM), Ally Financial (ALLY), Berry Global Group (BERY) and Air Canada (AC). Who are Alliance Pharma's key executives? Alliance Pharma's management team includes the folowing people: Mr. Peter Jonathan Butterfield, CEO & Exec. Director (Age 43)Mr. John Dawson, Founder & Non-Exec. Director (Age 70)Mr. Andrew Timothy Franklin, CFO & Exec. Director (Age 53)Mr. Stephen Kidner, Chief Scientific & Operations OfficerMr. Daniel Thomas, Chief Corp. Devel. Officer How do I buy shares of Alliance Pharma? Shares of APH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Alliance Pharma's stock price today? One share of APH stock can currently be purchased for approximately GBX 79.77. How big of a company is Alliance Pharma? Alliance Pharma has a market capitalization of £419.69 million and generates £129.76 million in revenue each year. Alliance Pharma employs 200 workers across the globe.View Additional Information About Alliance Pharma. What is Alliance Pharma's official website? The official website for Alliance Pharma is http://www.alliancepharma.co.uk/. How can I contact Alliance Pharma? Alliance Pharma's mailing address is Avonbridge House, Bath Road, CHIPPENHAM, SN15 2BB, United Kingdom. The company can be reached via phone at +44-1249-466966. MarketBeat Community Rating for Alliance Pharma (LON APH)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 187 (Vote Outperform)Underperform Votes: 241 (Vote Underperform)Total Votes: 428MarketBeat's community ratings are surveys of what our community members think about Alliance Pharma and other stocks. Vote "Outperform" if you believe APH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: What Factors Can Affect Return on Equity?
